Abstract:It is now clear that major malignancies are heterogeneous diseases associated with diverse molecular properties and clinical outcomes, posing a great challenge for more individualized therapy. In the last decade, cancer molecular subtyping studies were mostly based on transcriptomic profiles, ignoring heterogeneity at other (epi-)genetic levels of gene regulation. Integrating multiple types of (epi)genomic data generates a more comprehensive landscape of biological processes, providing an opportunity to better dissect cancer heterogeneity. Here, we propose sparse canonical correlation analysis for cancer classification (SCCA-CC), which projects each type of single-omics data onto a unified space for data fusion, followed by clustering and classification analysis. Without loss of generality, as case studies, we integrated two types of omics data, mRNA and miRNA profiles, for molecular classification of ovarian cancer ( n = 462), and breast cancer ( n = 451). The two types of omics data were projected onto a unified space using SCCA, followed by data fusion to identify cancer subtypes. The subtypes we identified recapitulated subtypes previously recognized by other groups (all P - values < 0.001), but display more significant clinical associations. Especially in ovarian cancer, the four subtypes we identified were significantly associated with overall survival, while the taxonomy previously established by TCGA did not ( P- values: 0.039 vs. 0.12). The multi-omics classifiers we established can not only classify individual types of data but also demonstrated higher accuracies on the fused data. Compared with iCluster, SCCA-CC demonstrated its superiority by identifying subtypes of higher coherence, clinical relevance, and time efficiency. In conclusion, we developed an integrated bioinformatic framework SCCA-CC for cancer molecular subtyping. Using two case studies in breast and ovarian cancer, we demonstrated its effectiveness in identifying biologically meaningful and clinically relevant subtypes. SCCA-CC presented a unique advantage in its ability to classify both single-omics data and multi-omics data, which significantly extends the applicability to various data types, and making more efficient use of published omics resources.

Subtype-WGME enables whole-genome-wide multi-omics cancer subtyping

Subtype-GAN: a deep learning approach for integrative cancer subtyping of multi-omics data

Subtype-MGTP: a cancer subtype identification framework based on multi-omics translation

Subtype-Former: a deep learning approach for cancer subtype discovery with multi-omics data

Evaluation and comparison of multi-omics data integration methods for cancer subtyping

Subtype-DCC: decoupled contrastive clustering method for cancer subtype identification based on multi-omics data

Multi-omics integration with weighted affinity and self-diffusion applied for cancer subtypes identification

Multi-view contrastive clustering for cancer subtyping using fully and weakly paired multi-omics data

Multi-Omics Data Fusion for Cancer Molecular Subtyping Using Sparse Canonical Correlation Analysis

Molecular Subtyping of Cancer Based on Robust Graph Neural Network and Multi-Omics Data Integration

MRGCN: cancer subtyping with multi-reconstruction graph convolutional network using full and partial multi-omics dataset

MDICC: novel method for multi-omics data integration and cancer subtype identification

A Contrastive-Learning-Based Deep Neural Network for Cancer Subtyping by Integrating Multi-Omics Data

Multi-layer matrix factorization for cancer subtyping using full and partial multi-omics dataset

Multi-Omics Data Fusion via a Joint Kernel Learning Model for Cancer Subtype Discovery and Essential Gene Identification

Integration of multi-omics data reveals a novel hybrid breast cancer subtype and its biomarkers

Identification of subtypes in digestive system tumors based on multi-omics data and graph convolutional network

Supervised Graph Clustering for Cancer Subtyping Based on Survival Analysis and Integration of Multi-Omic Tumor Data

Cancer subtype identification by multi-omics clustering based on interpretable feature and latent subspace learning

Identifying cancer subtypes in glioblastoma by combining genomic, transcriptomic and epigenomic data

Cancer subtype identification by consensus guided graph autoencoders